Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02715752 · ClinicalTrials.gov registry record
A Retrospective Chart Review Study of Gene-Eden-VIR/Novirin
A clinical trial of Human Papilloma Virus and Cytomegalovirus Infections, sponsored by The Center for the Biology of Chronic Disease.
- Completed
- Registry status
- 1,000
- Enrollment target
- 1
- Study location
NCT02715752: Completed study of Human Papilloma Virus and Cytomegalovirus Infections, sponsored by The Center for the Biology of Chronic Disease.
NCT02715752 is a study of Human Papilloma Virus and Cytomegalovirus Infections that has completed, run by The Center for the Biology of Chronic Disease. The registered enrollment target is 1,000 participants, below the 8,416-participant average among 39 other Human Papilloma Virus trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02715752, a study of Human Papilloma Virus and Cytomegalovirus Infections, has completed, sponsored by The Center for the Biology of Chronic Disease.
- COMPLETED
- Registry status
- 1,000 participants
- Enrollment target
- 1
- Study location
Study Summary
This study measured the changes in health-related complaints by analyzing charts of individuals, who are infected with a latent virus, who have used Gene-Eden-VIR/Novirin.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Gene-Eden-VIR/Novirin
Study Locations (1)
New York
- The Center for the Biology of Chronic Disease - Valley Cottage
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2016-01 |
| Est. Completion | 2016-03 |
What the finished NCT02715752 record still lists
NCT02715752 is an observational study that tracks outcomes without assigning an intervention. Its 1,000 participants enrollment target places it among the larger protocols in the corpus, below the 8,416-participant average among 39 other Human Papilloma Virus trials with a reported enrollment target (88% lower).
The record links to 5 conditions, with Human Papilloma Virus appearing as the primary indexed condition, and to 1 intervention - of which Gene-Eden-VIR/Novirin is the first listed.
NCT02715752 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT02715752 about?
NCT02715752 is a clinical study titled "A Retrospective Chart Review Study of Gene-Eden-VIR/Novirin". This study measured the changes in health-related complaints by analyzing charts of individuals, who are infected with a latent virus, who have used Gene-Eden-VIR/Novirin.
What is the current status of trial NCT02715752?
This trial is currently completed. The enrollment target is 1,000 participants. The study started on 2016-01. Estimated completion is 2016-03.
What conditions does trial NCT02715752 study?
This clinical trial studies the following conditions: Human Papilloma Virus, Cytomegalovirus Infections, Epstein-Barr Virus Infections, Varicella Zoster Virus Infection, Herpes Simplex Infections.
What interventions are being tested in trial NCT02715752?
The interventions under investigation include: Gene-Eden-VIR/Novirin (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02715752?
This trial is sponsored by The Center for the Biology of Chronic Disease, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02715752 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Human Papilloma Virus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02715752's enrollment target sits among peer trials
1,000 7th of 39 higher than 31 of 39 other Human Papilloma Virus trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Human Papilloma Virus trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Educate and Improve Underserved Populations' Uptake and Completion of the HPV Vaccine
RECRUITING · NA
-
Evaluating Gardasil HPV Vaccine Humoral and Cellular Immune Responses in People With and Without HIV
RECRUITING · Phase 2
-
PopSci CHW4CervixHealth
RECRUITING · NA
-
Multidimensional and Multimodal Profiling of Oropharyngeal Carcinoma
RECRUITING
-
Merck IIT: RRP Pembro and Lenvatinib
RECRUITING · Early Phase 1
-
TheraT® Vectors (Vaccines) Combined With Chemotherapy to Treat HPV16 Head and Neck Cancers
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00018044 · 1,000 participants
Study of Mycobacterial Infections
- NCT01036581 · 1,000 participants · NA
Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging
- NCT01192048 · 1,000 participants
Genetics of Congenital Heart Disease
- NCT01553214 · 1,000 participants · Phase 4
Improving White Blood Cell Collection From Healthy Donors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia